Carbapénème dérivé < Carbidopa < Carbonate dehydratase

Facettes :

List of bibliographic references indexed by Carbidopa

Number of relevant bibliographic references: 28.
[0-20] [0 - 20][0 - 28][20-27][20-40]

Ident.	Authors (with country if any)	Title
000F40 (2012)	Thomas Müller [Allemagne] ; Thomas Haas [Allemagne] ; Sven Lütge [Allemagne] ; Marion Marg [Allemagne] ; Reinhard Ehret [Allemagne]	Trichophagia Affects Response to Duodenal Levodopa/Carbidopa Gel Administration
000F87 (2012)	Fabian Klostermann [Allemagne] ; Constanze Jugel [Allemagne] ; Miriam Bömelburg [Allemagne] ; Frank Marzinzik [Allemagne] ; Georg Ebersbach [Allemagne] ; Thomas Müller [Allemagne]	Severe Gastrointestinal Complications in Patients With Levodopa/Carbidopa Intestinal Gel Infusion
001207 (2012)	Lissa S. Brod [États-Unis] ; Jason L. Aldred [États-Unis] ; John G. Nutt [États-Unis]	Are High Doses of Carbidopa a Concern? A Randomized, Clinical Trial in Parkinson's Disease
001738 (2011)	Aristide Merola [Italie] ; Maurizio Zibetti [Italie] ; Serena Angrisano [Italie] ; Laura Rizzi [Italie] ; Michele Lanotte [Italie] ; Leonardo Lopiano [Italie]	Comparison of subthalamic nucleus deep brain stimulation and Duodopa in the treatment of advanced Parkinson's disease
001858 (2011)	Anne Marthe Meppelink [Pays-Bas] ; Rickard Nyman [Suède] ; Teus Van Laar [Pays-Bas] ; Martje Drent [Pays-Bas] ; Ted Prins [Pays-Bas] ; Klaus Leonhard Leenders [Pays-Bas]	Transcutaneous Port for Continuous Duodenal Levodopa/ Carbidopa Administration in Parkinson's Disease
001B87 (2010)	Fabrizio Stocchi [Italie] ; Mario Zappia [Italie] ; Valentina Dall'Armi [Italie] ; Jaime Kulisevsky [Espagne] ; Paolo Lamberti [Italie] ; José Angel Obeso [Espagne]	Melevodopa/carbidopa effervescent formulation in the treatment of motor fluctuations in advanced Parkinson's disease
001D77 (2010)	William G. Ondo [États-Unis] ; Lina Shinawi [États-Unis] ; Steven Moore [États-Unis]	Comparison of orally dissolving carbidopa/levodopa (Parcopa) to conventional oral carbidopa/levodopa: A single‐dose, double‐blind, double‐dummy, placebo‐controlled, crossover trial
001E17 (2010)	Nasim R. Khadem [États-Unis] ; Melissa J. Nirenberg [États-Unis]	Carbidopa/levodopa pharmacy errors in Parkinson's disease
002105 (2009)	Victor S. C. Fung [Australie] ; Lilie Herawati [Australie] ; Ying Wan [États-Unis]	Quality of life in early Parkinson's disease treated with levodopa/carbidopa/entacapone
002342 (2009)	Robert A. Hauser [États-Unis] ; Michel Panisset [Canada] ; Giovanni Abbruzzese [Italie] ; Linda Mancione [États-Unis] ; Nalina Dronamraju [États-Unis] ; Algirdas Kakarieka [Suisse]	Double‐blind trial of levodopa/carbidopa/entacapone versus levodopa/carbidopa in early Parkinson's disease
002E79 (2007)	Angelo Antonini [Italie] ; Ioannis U. Isaias [Italie] ; Margherita Canesi [Italie] ; Maurizio Zibetti [Italie] ; Francesca Mancini [Italie] ; Luigi Manfredi [Italie] ; Marco Dal Fante [Italie] ; Leonardo Lopiano [Italie] ; Gianni Pezzoli [Italie]	Duodenal levodopa infusion for advanced Parkinson's disease: 12‐month treatment outcome
002F74 (2007)	David B. Fitzgerald [États-Unis] ; Valeria Drago [États-Unis] ; Dean Sutherland [États-Unis] ; Kenneth M. Heilman [États-Unis]	Carbidopa/levodopa–responsive myoclonus
004053 (2003)	Jau-Shin Lou [États-Unis] ; Greg Kearns [États-Unis] ; Theodore Benice [États-Unis] ; Barry Oken [États-Unis] ; Gary Sexton [États-Unis] ; John Nutt [États-Unis]	Levodopa improves physical fatigue in Parkinson's disease: A double‐blind, placebo‐controlled, crossover study
004316 (2002)	Robert A. Hauser [États-Unis] ; Nicholas H. G. Holford [Nouvelle-Zélande]	Quantitative description of loss of clinical benefit following withdrawal of levodopa–carbidopa and bromocriptine in early Parkinson's disease
004475 (2002)	Ashfaq A. Sharif [États-Unis]	Entacapone in restless legs syndrome
004933 (2000)	Robert A. Hauser [États-Unis] ; William C. Koller [États-Unis] ; Jean P. Hubble [États-Unis] ; Teresita Malapira [États-Unis] ; Karen Busenbark [États-Unis] ; C. Warren Olanow [États-Unis]	Time course of loss of clinical benefit following withdrawal of levodopa/carbidopa and bromocriptine in early Parkinson's disease
004D56 (1999)	Robert B. Innis ; Kenneth L. Marek ; Kim Sheff ; Sami Zoghbi ; Joseph Castronuovo [États-Unis] ; Andrew Feigin [États-Unis] ; John P. Seibyl	Effect of treatment with L‐dopa/carbidopa or L‐selegiline on striatal dopamine transporter SPECT imaging with [123I]β‐CIT
004E99 (1998)	P. Van Den Munckhof [États-Unis] ; F. A. Lenz [États-Unis] ; T. N. Chase [États-Unis] ; L. Verhagen Metman [États-Unis]	Square‐wave action dystonia in Parkinson's disease
004F27 (1998)	Paul G. Wasielewski [États-Unis] ; Jeffrey M. Burns [États-Unis] ; William C. Koller [États-Unis]	Pharmacologic Treatment of Tremor
005231 (1997)	Eric J. Pappert [États-Unis] ; Jack W. Lipton [États-Unis] ; Christopher G. Goetz [États-Unis] ; Zao D. Ling [États-Unis] ; Glenn T. Stebbins [États-Unis] ; Paul M. Carvey [États-Unis]	The stability of carbidopa in solution
005338 (1997)	Ken Ikeda [Japon] ; Masao Kinoshita [Japon] ; Kazuya Aoki [Japon] ; Atsushi Tomatsuri [Japon]	Hydrocephalic parkinsonism due to Paget's disease of bone: Dramatic improvement following ventriculoperitoneal shunt and temporary levodopa/carbidopa therapy

---

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Santé/explor/MovDisordV3/Data/Main/Exploration

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/PascalFr.i -k "Carbidopa" 

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/PascalFr.i  \
                -Sk "Carbidopa" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Santé
   |area=    MovDisordV3
   |flux=    Main
   |étape=   Exploration
   |type=    indexItem
   |index=    PascalFr.i
   |clé=    Carbidopa
}}

---

This area was generated with Dilib version V0.6.23. Data generation: Sun Jul 3 12:29:32 2016. Site generation: Wed Feb 14 10:52:30 2024